Neutral Sodium Fluoride

Sodium Fluoride


Amd Medicom Inc.
Human Prescription Drug
NDC 64778-0239
Neutral Sodium Fluoride also known as Sodium Fluoride is a human prescription drug labeled by 'Amd Medicom Inc.'. National Drug Code (NDC) number for Neutral Sodium Fluoride is 64778-0239. This drug is available in dosage form of Gel. The names of the active, medicinal ingredients in Neutral Sodium Fluoride drug includes Sodium Fluoride - .02 g/mL . The currest status of Neutral Sodium Fluoride drug is Active.

Drug Information:

Drug NDC: 64778-0239
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Neutral Sodium Fluoride
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Prescription Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Sodium Fluoride
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Amd Medicom Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Gel
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:SODIUM FLUORIDE - .02 g/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:DENTAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED DRUG OTHER
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 23 Feb, 2017
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 19 Dec, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:AMD Medicom Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:245593
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:8ZYQ1474W7
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
64778-0239-312 BOTTLE, PLASTIC in 1 CASE (64778-0239-3) / 480 mL in 1 BOTTLE, PLASTIC (64778-0239-1)01 Dec, 2017N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Product Elements:

Neutral sodium fluoride sodium fluoride sodium fluoride fluoride ion

Indications and Usage:

Indications and directions indications: topical anti-carie preparation in a ph 7 thixotropic gel base. directions: following prophylaxis treatment, fll 1/3 of tray with gel insert tray in the patient’s mouth have patient bite down lightly for 4 minutes remove tray and have patient expectorate excess advise patient not to eat, drink or rinse for 30 minutes after application medicinal ingredients: fluoride ions 0.9% w/w (from 2% w/w neutral sodium fluoride)

Warnings and Cautions:

Warnings keep out of reach of children. for professional use only. store at room temperature. do not expose to excessive heat over 40ºc or 104ºf. do not use if seal is broken.

Description:

General information amd medicom inc. denticare pro-gel 2% neutral sodium fluoride gel topical fluoride applications (0.9% fluoride ions) strawberry 16.23 fl oz / 480 ml ndc 64778-0239-1 npn 80008850 rx only for us item code 10023-st

Package Label Principal Display Panel:

Prinicipal display panel panel 1


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.